Nelarabine activity in acute biphenotypic leukemia. 2007

Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
April 1991, British journal of haematology,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
July 1990, American journal of clinical pathology,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
May 2006, Clinical rheumatology,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
August 1999, Haematologica,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
January 1997, Haematologica,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
June 1993, Leukemia,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
May 1991, Cancer genetics and cytogenetics,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
July 2002, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
May 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Yesid Alvarado, and Mary Alma Welch, and Ronan Swords, and John Bruzzi, and Ellen Schlette, and Francis J Giles
May 2002, Ai zheng = Aizheng = Chinese journal of cancer,
Copied contents to your clipboard!